The Wave of New Vaccines

The wave
of new vaccines


  • Key Fact 1

    Founded by Nobel Prize Winner
    Prof. Dr. Rolf Zinkernagel's laboratory

  • Key Fact 2

    Based on powerful vaccine platforms Vaxwave® and TheraT®

  • Key Fact 3

    Led by seasoned vaccine business and industrial leaders

  • Key Fact 4

    Supported by blue chip VC investors

Latest News

17.10.2016 // Hookipa Secures ‎EUR 4.16 million Additional Grant Support from the Austrian Research Promotion Agency (FFG) to Develop Arenavirus Vector-Based Cancer Immunotherapies
11.10.2016 // Dr. Torsten Mummenbrauer Appointed SVP Business Development & Licensing of Hookipa Biotech
20.7.2016 // Hookipa Biotech Initiates First-in-Human Study of Cytomegalovirus Vaccine